Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This information helps healthcare providers assess potential interactions and adjust treatment plans accordingly
To evaluate if 0.04% MMC application at the ostium enhances the outcome of non-endoscopic endonasal dacryocystorhinostomy (NEED) in individuals with primary acquired nasolacrimal duct obstruction (PANDO)
NAGly, N-arachidonic glycine
From an email I sent Thursday evening to book EBOO, I was called back first thing Friday and accommodated with same day OZONE treatment followed by EBOO Monday morning
US$ 27.98
US$ 24.46
US$ 27.98
US$ 25.36
US$ 28.43
US$ 24.52
